Oral Oncology
Volume 38, Issue 6 , Pages 549-556 , September 2002

Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongue

  • H Goto

      Affiliations

    • Department of Oral and Maxillo-Facial Surgery, Faculty of Medicine, Oita Medical University, 1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan
    • ,
  • K Kawano

      Affiliations

    • Department of Oral and Maxillo-Facial Surgery, Faculty of Medicine, Oita Medical University, 1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-97-586-6703; fax: +81-97-549-2838
    • ,
  • I Kobayashi

      Affiliations

    • Section of Oral Diagnostic Science, Division of Maxillofacial Diagnostic and Surgical Science, Faculty of Dental Science, University of Kyusyu, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
    • ,
  • H Sakai

      Affiliations

    • Section of Oral Pathology and Medicine, Division of Maxillofacial Diagnostic and Surgical Science, Faculty of Dental Science, University of Kyusyu, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
    • ,
  • S Yanagisawa

      Affiliations

    • Department of Oral and Maxillo-Facial Surgery, Faculty of Medicine, Oita Medical University, 1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan

Received 1 October 2001 ,Accepted 17 October 2001.

References 

  1. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta. 1993;1155:63–78
  2. Lam KY, Ng IOL, Yuen APW, Kwong DLW, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med. 2000;29:167–172
  3. Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridam BF, Jensen MJ, et al.  Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res. 1999;5:2810–2819
  4. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, et al.  Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer. 1997;74:576–581
  5. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Harada H, et al.  Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol. 2000;36:194–198
  6. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 1995;55:975–978
  7. Batsakis JG. Tumors of the head and neck. Clinical and pathological considerations. 1st ed. Baltimore: Williams & Wilkins Company; 1974;
  8. Rousseau A, Lim MS, Lin Z, Jordan RCK. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol. 2001;37:268–275
  9. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998;12:3499–3511
  10. Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WFO, et al.  A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity. Carcinogenesis. 2000;21:1537–1546
  11. Sobin LH, Wittekind Ch. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997;
  12. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin: Springer; 1997;
  13. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973;12:1–8
  14. Kanda Y, Nishiyama Y, Shimada Y, Imamura M, Nomura H, Hiai H, et al.  Analysis of gene amplification and overexpression in human esophageal-caricnoma cell lines. Int J Cancer. 1994;58:291–297
  15. Takes RP, Baatenburg de Jong RJ, Schuurink E, Litvinov SV, Hermans J, van Krieken JHJM. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res. 1998;18:4793–4800
  16. Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995;55:949–956
  17. Åkervall JA, Michalides RJAM, Mineta H, Balm A, Ake B, Dictor MR, et al.  Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 1997;79:380–389
  18. Mineta H, Borg A, Dictor M, Wahlberg P, Wennerberg J. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncol. 1997;33:42–46
  19. Callendar T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152–158
  20. Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, et al.  Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene. 1999;18:3541–3545
  21. Schneeberger C, Eder S, Swoboda H, Ullrich R, Zeillinger R. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas. Oral Oncol. 1998;34:257–260
  22. Monden N, Nishizaki K, Fukushima K, Masuda Y, Tsukuda K, Shimizu K. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas. Jpn J Cancer Res. 1997;88:660–668
  23. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, et al.  PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813–4817
  24. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 1998;58:2876–2880
  25. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, et al.  Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res. 1997;57:1634–1637
  26. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426
  27. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, et al.  β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 2000;97:4262–4266
  28. Qiao Q, Ramadani M, Gansauge S, Gansauge F, Leder G, Beger HG. Reduced membranous and ectopic cytoplasmic expression of β-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer. 2001;95:194–197
  29. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, et al.  Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res. 1999;19:3817–3826
  30. Shintani S, Mihara M, Ueyama Y, Matsumura T, Wong DTW. Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma. Int J Cancer 2001;96:159–65.

PII: S1368-8375(01)00121-X

Oral Oncology
Volume 38, Issue 6 , Pages 549-556 , September 2002

Article Tools

* Image Usage & Resolution